Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain



Status:Not yet recruiting
Conditions:Cancer, Brain Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 60
Updated:2/23/2019
Start Date:May 1, 2019
End Date:December 31, 2022

Use our guide to learn which trials are right for you!

Investigators propose to develop hyperpolarized [13C]-labeled pyruvate as potential imaging
probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism
and synthesis of a neurotransmitter.

Investigators will perform a pilot study to test the translational feasibility by evaluating
sensitivity and repeatability of hyperpolarized [1-13C]pyruvate and [2-13C]pyruvate in
healthy human subjects (n =10 each). Each subject will be imaged twice using the same
hyperpolarized substrate with an interval (<45min) between the injections to evaluate
repeatability. Finally, eight subjects will be imaged with both hyperpolarized
[1-13C]pyruvate and [2-13C]pyruvate for comparison.

Inclusion Criteria:

- 18 through 60 years of age.

- Healthy, with no neurological abnormalities.

- Ability to understand and the willingness to sign a written informed consent.

- All races and ethnicities will be included; subjects must be able to read and speak
the English or Spanish language.

Exclusion Criteria:

- Metallic foreign bodies on the scalp or cranium which may interfere with MRI
acquisitions

- Major debilitating neurological disease including, but not limited to, stroke, CVA,
dementia and tumor that would limit compliance with study requirements

- Under influence of illicit drugs which are known to alter brain physiology/metabolism
including, but not limited to cocaine, lysergic acid diethylamide (LSD), and marijuana
at the time of MRI/MRSI scanning.

- Under influence of antiepileptic drugs at the time of MRI/MRSI scanning.

- Any contraindication per MRI Screening Form including

- Implants contraindicated at 3T, pacemakers

- Implantable Cardioverter Defibrillator (ICD)

- Claustrophobia

- Medically unstable including

- Heart failure

- Severe left ventricular outflow tract (LVOT) obstruction

- Unstable angina

- Pregnancy

- Lactating
We found this trial at
1
site
?
mi
from
Dallas, TX
Click here to add this to my saved trials